Express Pharma - Express Pharma

Decision follows results of interim futility analysis which indicate phase-III REALM-DCM trial unlikely to meet primary endpoint

Bhupendra Pratap Singh Chauhan, CQA Head, Morepen Laboratories, started his address by sharing some facts and figures with the…

Beginning his presentation, NVS Vishal, Business Development Executive, Omega Scientific Instruments, informed about the company's…

It is the first and only approved medicine targetting BRCA mutations in early breast cancer

Dr Anoop Kumar, Head, Market Development and Marketing, SCIEX, began his presentation by sharing a brief about his company with…

While speaking at the summit, Dr Deo Narain Dikshit, Consultant, Pharma Quality, Compliance and Manufacturing process notified…

Addressing the issue of supply chain resilience, Dr Sanjit Singh Lamba, CEO, Valence Labs, informed that supply chain risks have…

Dhairy Sharma, Technical Sales, Cilicant, began his presentation by thanking Mehta for his keynote address, wherein he widely…

Upendra Singh Bisht, Manager—Business Development, Ami Polymer, talked about the varities of polymer range, which include…

Ripan Mehta, Assistant State Drugs Controller, Haryana, FDA, initiated his keynote address by shedding light on the quality of…